Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-014-2659-6
Published Online: 2014-12-28
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyazaki, Tatsuya
Sohda, Makoto
Tanaka, Naritaka
Suzuki, Shigemasa
Ieta, Keisuke
Sakai, Makoto
Sano, Akihiko
Yokobori, Takehiko
Inose, Takanori
Nakajima, Masanobu
Fukuchi, Minoru
Ojima, Hitoshi
Kato, Hiroyuki
Kuwano, Hiroyuki
Text and Data Mining valid from 2014-12-28